Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change?
No Thumbnail Available
Identifiers
Date
2021-11-11
Authors
Jimenez-Ubieto, Ana
Paiva, Bruno
Puig, Noemi
Cedena, Maria-Teresa
Martinez-Lopez, Joaquin
Oriol, Albert
Blanchard, Maria-Jesus
Rios, Rafael
Martin, Jesus
Martinez, Rafael
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Amer soc hematology
Abstract
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
Minimal residual disease, Multiple-myeloma, Transplantation, Bortezomib, Therapy